A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

CRSP reports encouraging fourth-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is ...

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta—a hallmark of Alzheimer's disease. The findings ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body’s immune response ...

The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...

An increased risk of dementia among individuals exposed to brain trauma, traumatic brain injury, has been known for almost a century.

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their ...